MetLife Investment Management’s Astronics ATRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.52M | Sell |
18,727
-1,548
| -8% | -$106K | 0.01% | 1308 |
|
|
2026
Q1 | $1.13M | Sell |
20,275
-683
| -3% | -$41.2K | 0.01% | 1340 |
|
|
2025
Q4 | $947K | Hold |
20,958
| – | – | ﹤0.01% | 1458 |
|
|
2025
Q3 | $797K | Buy |
+20,958
| New | +$638K | ﹤0.01% | 1582 |
|
|
2025
Q2 | – | Sell |
-20,653
| Closed | -$416K | – | 2809 |
|
|
2025
Q1 | $416K | Sell |
20,653
-2,484
| -11% | -$41.8K | ﹤0.01% | 1814 |
|
|
2024
Q4 | $308K | Buy |
23,137
+3,530
| +18% | +$51.9K | ﹤0.01% | 2058 |
|
|
2024
Q3 | $318K | Hold |
19,607
| – | – | ﹤0.01% | 2032 |
|
|
2024
Q2 | $327K | Buy |
19,607
+2,832
| +17% | +$43.9K | ﹤0.01% | 1955 |
|
|
2024
Q1 | $266K | Hold |
16,775
| – | – | ﹤0.01% | 2034 |
|
|
2023
Q4 | $244K | Hold |
16,775
| – | – | ﹤0.01% | 2123 |
|
|
2023
Q3 | $222K | Hold |
16,775
| – | – | ﹤0.01% | 2149 |
|
|
2023
Q2 | $278K | Hold |
16,775
| – | – | ﹤0.01% | 2063 |
|
|
2023
Q1 | $187K | Hold |
16,775
| – | – | ﹤0.01% | 2264 |
|
|
2022
Q4 | $144K | Hold |
16,775
| – | – | ﹤0.01% | 2433 |
|
|
2022
Q3 | $110K | Hold |
16,775
| – | – | ﹤0.01% | 2638 |
|
|
2022
Q2 | $142K | Hold |
16,775
| – | – | ﹤0.01% | 2522 |
|
|
2022
Q1 | $181K | Buy |
16,775
+5,893
| +54% | +$64.1K | ﹤0.01% | 2409 |
|
|
2021
Q4 | $109K | Buy |
10,882
+7,458
| +218% | +$78.3K | ﹤0.01% | 2378 |
|
|
2021
Q3 | $40.1K | Sell |
3,424
-7,603
| -69% | -$96.5K | ﹤0.01% | 2541 |
|
|
2021
Q2 | $161K | Buy |
11,027
+6,624
| +150% | +$96.1K | ﹤0.01% | 2292 |
|
|
2021
Q1 | $66.2K | Sell |
4,403
-8,484
| -66% | -$110K | ﹤0.01% | 2272 |
|
|
2020
Q4 | $142K | Buy |
+12,887
| New | +$106K | ﹤0.01% | 2147 |
|
|
2020
Q3 | – | Sell |
-12,458
| Closed | -$110K | – | 2299 |
|
|
2020
Q2 | $110K | Hold |
12,458
| – | – | ﹤0.01% | 2214 |
|
|
2020
Q1 | $95.3K | Hold |
12,458
| – | – | ﹤0.01% | 2102 |
|
|
2019
Q4 | $290K | Hold |
12,458
| – | – | ﹤0.01% | 1772 |
|
|
2019
Q3 | $305K | Hold |
12,458
| – | – | ﹤0.01% | 1695 |
|
|
2019
Q2 | $418K | Sell |
12,458
-24,917
| -67% | -$783K | ﹤0.01% | 1591 |
|
|
2019
Q1 | $1.02M | Buy |
37,375
+24,917
| +200% | +$664K | ﹤0.01% | 1649 |
|
|
2018
Q4 | $316K | Sell |
12,458
-1,869
| -13% | -$49.2K | ﹤0.01% | 1645 |
|
|
2018
Q3 | $452K | Hold |
14,327
| – | – | ﹤0.01% | 1600 |
|
|
2018
Q2 | $373K | Hold |
14,327
| – | – | ﹤0.01% | 1591 |
|
|
2018
Q1 | $387K | Hold |
14,327
| – | – | ﹤0.01% | 1530 |
|
|
2017
Q4 | $431K | Buy |
+14,327
| New | +$388K | ﹤0.01% | 1482 |
|
Other funds holding ATRO
PP
NCGI
MetLife Investment Management's ATRO Position: Q2 2026 in Review
MetLife Investment Management reduced its Astronics (ATRO) stake by 7.6% in Q2 2026, selling an estimated $106K and leaving 18,727 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #1308.
MetLife Investment Management first reported a position in ATRO in Q4 2017 and has held it in 33 quarters since. 311 funds tracked by Wall St. Rank hold ATRO as of Q2 2026.
- MetLife Investment Management held 18,727 shares of Astronics worth $1.52M as of Q2 2026.
- MetLife Investment Management sold 1,548 Astronics shares in Q2 2026, an estimated $106K.
- Astronics made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1308 holding.
- MetLife Investment Management first reported a position in Astronics in Q4 2017 and has held it in 33 quarters since.
- 311 funds tracked by Wall St. Rank held Astronics as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.